CATALANO, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 10.320
EU - Europa 856
AS - Asia 439
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 11.621
Nazione #
US - Stati Uniti d'America 10.319
DE - Germania 259
SG - Singapore 226
CN - Cina 149
UA - Ucraina 136
IT - Italia 115
IE - Irlanda 112
RU - Federazione Russa 67
GB - Regno Unito 51
KR - Corea 41
FR - Francia 33
FI - Finlandia 31
SE - Svezia 20
BE - Belgio 13
JP - Giappone 7
PL - Polonia 6
VN - Vietnam 5
CH - Svizzera 4
IN - India 4
A2 - ???statistics.table.value.countryCode.A2??? 2
EU - Europa 2
GR - Grecia 2
HK - Hong Kong 2
LT - Lituania 2
UZ - Uzbekistan 2
AT - Austria 1
AZ - Azerbaigian 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
IR - Iran 1
NL - Olanda 1
RO - Romania 1
TR - Turchia 1
Totale 11.621
Città #
Woodbridge 3.204
Wilmington 2.704
Houston 2.470
Fairfield 274
Ann Arbor 234
Chandler 206
Singapore 205
Ashburn 156
Seattle 129
Jacksonville 126
Cambridge 100
Dublin 99
Medford 76
Dearborn 61
New York 56
Santa Clara 56
Rome 50
Zhengzhou 49
Beijing 45
Lawrence 36
San Diego 21
Menlo Park 17
Mülheim 17
Milan 13
Brussels 12
Moscow 12
Shanghai 10
Norwalk 9
London 8
Nürnberg 8
Falls Church 7
Mountain View 7
Hefei 6
University Park 6
Colorado Springs 5
Kunming 5
Boardman 4
Chicago 4
La Veta 4
Nanchang 4
Nuremberg 4
Phoenix 4
Redwood City 4
Verona 4
Brescia 3
Creede 3
Dong Ket 3
Kraków 3
Munich 3
Nanjing 3
Seoul 3
Wenzhou 3
Austin 2
Aversa 2
Chengdu 2
Council Bluffs 2
Del Norte 2
Hanoi 2
Hebei 2
Helsinki 2
Hong Kong 2
Jinan 2
Los Angeles 2
Palo Alto 2
Paris 2
Perugia 2
Pune 2
Sacramento 2
Saint Petersburg 2
San Mateo 2
San Venanzo 2
Simi Valley 2
Trieste 2
Xian 2
Yamazaki 2
Athens 1
Baku 1
Berlin 1
Billings 1
Brno 1
Budapest 1
Chiswick 1
Corona 1
Fuzhou 1
Guangzhou 1
Hounslow 1
Indiana 1
Kilburn 1
Kyoto 1
Lanzhou 1
Lappeenranta 1
Lausanne 1
Leawood 1
Malmo 1
Montagnola 1
Piraeus 1
Putian 1
Qingdao 1
Rzeszów 1
Salt Lake City 1
Totale 10.626
Nome #
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 461
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 456
A case of SRSF2 mutation in chronic lymphocytic leukemia 447
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity 422
Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms 411
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A New Class of Agents with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Who Were Imatinib-Resistant. 408
Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant 398
Benzodiazepine derivatives and uses thereof in medical field 392
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 390
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 390
Expression cDNA cloning of a novel oncogene with sequence similarity to regulators of small GTP-binding proteins 387
Imatinib-mesylate for all patients with hypereosinophilic syndrome? 386
null 385
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients 384
High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro 376
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant 375
“Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) induce apoptosis in primari chronic myelogenous leukemic cells”. 366
PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells. 364
Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors 358
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 355
Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant 355
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 354
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia 352
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 346
PML/RARA inhibits expression of HSP90 and its target AKT 322
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 316
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 306
Sarcoma di Kaposi e neoplasie linfoproliferative 306
[Current aspects of treatment of multiple myeloma] 285
PML/RARa interferes with NRF2 transcriptional activity increasing the sensitivity to ascorbate of acute promyelocytic leukemia cells 204
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies 180
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration 94
NPM1 mutated, BCR-ABL1 positive myeloid neoplasms: review of the literature 70
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation. 60
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment 58
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients 55
Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. 39
PLZF-RARΑ ENHANCES METABOLIC PLASTICITY AND ROS SCAVENGING IN AML CELLS 33
The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature 16
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes 15
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes 14
Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies 10
Totale 11.701
Categoria #
all - tutte 22.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.000 0 0 0 0 254 306 276 261 222 279 185 217
2020/20211.857 183 209 178 233 222 236 245 172 51 43 69 16
2021/2022370 15 55 8 25 11 24 26 13 22 25 24 122
2022/2023513 53 46 25 49 50 111 39 24 57 13 28 18
2023/2024202 29 7 17 8 25 65 3 1 3 5 6 33
2024/2025455 18 243 100 66 28 0 0 0 0 0 0 0
Totale 11.701